LoginRegister
    Reckitt Benckiser chief Rakesh Kapoor to step downReckitt Benckiser chief Rakesh Kapoor to step down
    HC Relief to Reckitt Benckiser in advertisement of ASU drugs caseHC Relief to Reckitt Benckiser in advertisement of ASU drugs case
    Fortis Healthcare to take Rs 1100 crore loan from CitibankFortis Healthcare to take Rs 1100 crore loan from Citibank
    Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019Paras Healthcare infuses Rs 500 crore to add 830 beds in 2019
    Medtronic launches MyCareLink Heart mobile app to let patients monitor their pacemakersMedtronic launches MyCareLink Heart mobile app to let patients monitor their pacemakers
    Abbott to acquire mitral valve device maker Cephea Valve TechnologiesAbbott to acquire mitral valve device maker Cephea Valve Technologies
    OxyContin maker Purdue Pharma accused of deceiving patients and doctorsOxyContin maker Purdue Pharma accused of deceiving patients and doctors
    Commercialisation of Ayush Drugs, Technologies: New policy calls for 4 percent royalty to CCRASCommercialisation of Ayush Drugs, Technologies: New policy calls for 4 percent royalty to CCRAS
    Cama Hospital: Tata Trust grants Rs 3 crore to restore building, build museumCama Hospital: Tata Trust grants Rs 3 crore to restore building, build museum
    Fortis completes acquisition of RHT assets at enterprise value of Rs 4650 croreFortis completes acquisition of RHT assets at enterprise value of Rs 4650 crore
    TAVR: Edward Lifesciences pays Boston Scientific $180 million to end patent disputeTAVR: Edward Lifesciences pays Boston Scientific $180 million to end patent dispute
    Pfizer says USFDA accepts regulatory submissions for review of tafamidisPfizer says USFDA accepts regulatory submissions for review of tafamidis
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X